Unlock instant, AI-driven research and patent intelligence for your innovation.

Pharmaceutical use of 1-(3-(6-chloropyridine)methyl)-3-phenyl-1H-pyrazol-5-carbohydrazide

A technology of carbohydrazide and chloropyridine, applied in the preparation of drugs for inhibiting vascular endothelial cell aging and apoptosis, field of 1-methyl)-3-phenyl-1H-pyrazole-5-carbohydrazide

Inactive Publication Date: 2012-12-26
SHANDONG UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] At present, there are few reports about pyrazole carbohydrazide derivatives, especially no 1-(3-(6-chloropyridyl)methyl)-3-phenyl-1H-pyrazole-5-carbohydrazide in the vascular endothelium. Reports on the role of cell senescence and apoptosis and related pharmacological research and application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical use of 1-(3-(6-chloropyridine)methyl)-3-phenyl-1H-pyrazol-5-carbohydrazide
  • Pharmaceutical use of 1-(3-(6-chloropyridine)methyl)-3-phenyl-1H-pyrazol-5-carbohydrazide
  • Pharmaceutical use of 1-(3-(6-chloropyridine)methyl)-3-phenyl-1H-pyrazol-5-carbohydrazide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0070] Example 1 Preparation of 1-(3-(6-chloropyridine)methyl)-3-phenyl-1H-pyrazole-5-carbohydrazide

[0071] 1) Add 0.690 gram of potassium carbonate (0.005 mol), 1.080 gram of 3-phenyl-1H-pyrazole-5-carboxylic acid ethyl ester (0.005 mol), 0.810 gram of 2-chloro-5- Chloromethylpyridine (0.005 mol) and acetonitrile (25 ml) were installed in a reflux condenser, and the upper part was connected to a drying tube. Heat to reflux for 4 hours, react until the raw material is completely consumed, and detect the end of the reaction by TLC. Concentrate under reduced pressure, remove the solvent, add ethyl acetate (30 ml) to dissolve the product, filter, the filtrate is concentrated, and use ethyl acetate-petroleum ether (V / V=1 / 2) as the eluent for silica gel column chromatography to separate the residue ( 100-200 mesh silica gel) to obtain ethyl 1-(3-(6-chloropyridine)methyl)-3-phenyl-1H-pyrazole-5-carboxylate;

[0072] 2) Add 1.2 Milliliter of 80% hydrazine hydrate was stirred and...

Embodiment 2

[0080] The cultured cells were divided into normal group cells, control group cells and treatment group cells.

[0081] Cells in the normal group were cultured with M199 medium containing serum and growth factors; cells in the control group were cultured without serum and growth factors; cells in the treatment group were treated with 1-(3-(6- Chloropyridine)methyl)-3-phenyl-1H-pyrazole-5-carbohydrazide treatment. After 24 hours of culture, the three groups of cells were fixed with 2% formaldehyde and 0.5% glutaraldehyde for 5 minutes, then washed once with the staining solution without β-galactose, and added the staining solution containing β-galactose at 37°C without carbon dioxide. Incubate under conditions for 18-24 hours. Observed after washing with PBS. Randomly select 10 fields of view for each of the above three groups of cells, count the total number of cells and the number of positive cells, and calculate the positive rate (see results under a microscope). Figure ...

Embodiment 3

[0085] The cultured cells were divided into normal group cells, control group cells and treatment group cells.

[0086] Cells in the normal group were cultured with M199 medium containing serum and growth factors; cells in the control group were cultured without serum and growth factors; cells in the treatment group were treated with 1-(3-(6- Chloropyridine)methyl)-3-phenyl-1H-pyrazole-5-carbohydrazide treatment. After the three groups of cells were cultured for 24 hours, the culture medium was discarded and fixed with 4% paraformaldehyde for 15 minutes. After washing with 0.1M PBS, normal serum blocking solution was added. Discard the blocking solution, add the primary antibody, discard the primary antibody and add the secondary antibody, keep at 37°C for 30 minutes, discard the secondary antibody, wash with 0.1M PBS and observe.

[0087] Fluorescent quantitative analysis was performed on the expression of cell membrane integrin β4 in the above three groups.

[0088] The r...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses the use of 1-(3-(6-chloropyridine)methyl)-3-phenyl-1H-pyrazol-5-carbohydrazide in the preparation of medicines for inhibiting aging and apoptosis of vascular endothelial cells, wherein the concentration of the 1-(3-(6-chloropyridine)methyl)-3-phenyl-1H-pyrazol-5-carbohydrazide which can effectively inhibit apoptosis, nuclear fragmentation and DNA condensation is 20 to 60 mg / L. The invention provides a new development and use approach for the preparation of medicines for inhibiting aging and apoptosis of vascular endothelial cells and treatment of cardiovascular diseases.

Description

technical field [0001] The present invention relates to the application of pyrazole carbohydrazide derivatives in inhibiting vascular endothelial cell aging and apoptosis; especially 1-(3-(6-chloropyridine)methyl)-3-phenyl-1H-pyrazole- Application of 5-carbohydrazide in the preparation of drugs for inhibiting vascular endothelial cell aging and apoptosis. Background technique [0002] The structural formula of 1-(3-(6-chloropyridine)methyl)-3-phenyl-1H-pyrazole-5-carbohydrazide is as follows: [0003] [0004] Molecular formula: C 16 h 14 ClN 5 o [0005] Molecular weight: 327.77 [0006] Properties: white solid. [0007] At present, there are few reports about pyrazole carbohydrazide derivatives, especially no 1-(3-(6-chloropyridyl)methyl)-3-phenyl-1H-pyrazole-5-carbohydrazide in the vascular endothelium. Reports on the role of cell senescence and apoptosis, as well as related pharmacological research and application. Contents of the invention [0008] Aiming a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/4439A61P9/00A61P9/14
Inventor 张尚立张恒常宏文马剑峰王丽王萍
Owner SHANDONG UNIV